Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain
| Autor: | Roitberg, F., Amaral, T., Cherny, N.I., Giuliani, R., Latino, N.J., Galotti, M., Bricalli, G., Curigliano, G., Pentheroudakis, G., Trapani, D. |
|---|---|
| Zdroj: | In ESMO Open October 2023 8(5) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|